• Home
• Conference Coverage
• Event Calendar
• UroToday International Journal
• Advanced Search

Search    Display 5 10 15 20 25 30 50 results per page Results 1 - 4 of 4 << Start < Prev 1 Next > End >> European Urology is “Your” Journal Monday, 02 January 2006 Francesco Montorsi published online 14 November 2005. Dear Reader, It is a major honour and privilege to write to you today as the new Editor-in-Chief of European Urology. read more Drug treatment for LUTS and BPH: New is not always better Monday, 02 January 2006 Claus G. Roehrborn, University of Texas, Southwestern Medical Center at Dallas Medical therapy for lower urinary tract symptoms (LUTS), the most common manifestation of benign prostatic hyperplasia (BPH), has been firmly established in our therapeutic armamentarium for nearly 15 years. It was in the early 1990's that the selective long-acting alpha blocker terazosin and doxazosin were introduced, and just a few years later that the first 5 alpha reductase inhibitor finasteride entered the market place. read more The Future of Oncological Urology in Europe: Are we Prepared? Monday, 02 January 2006 Dokuz Eylul University School of Medicine Department of Urology, Izmir, Turkey Oncological urology constitutes a major part of the general urologist’s daily practice. Urological tumors are quite common solid tumors among all human malignancies. Prostate cancer is the most common cancer in the male population and is the second most common cause of cancer deaths in the male [1,2].  read more Prostate Cancer: Fine Tuning our Ability to Accurately Grade and Stage the Disease Prior to Therapy Monday, 02 January 2006 Erasme Hospital, University Clinics of Brussels, 808 Route de Lennik, 1070 Brussels, Belgium In the last decade, we have witnessed numerous improvements and refinements in the diagnosis, staging and treatment of prostate cancer. However, an optimal management and therapeutical approach to this neoplasm is hampered by our relative inability to predict, with certainty, the exact pathological stage and aggressiveness of the neoplasm based on the results of biopsies only. read more   << Start < Prev 1 Next > End >> Results 1 - 4 of 4

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2009 UroToday ® All Rights Reserved